P.O. Box 681 Grovetown, Georgia
Feb 10 2008
Honorable Josh Green, MD
Honorable John Mizuno
Re: House Bill 2580 Room #329
I am a physician and truly disturbed by the continued availability of Aspartame in our food supply. As a resident physician I developed tremors in my dominant hand (right). These tremors affected my surgical performance to the point of having one of my professors inquire as to whether or not I had an alcohol problem.
I have researched the issue and found that there is a plethora of scientific evidence to substantiate the claim that Aspartame should have never been allowed to enter our food supply.
Several facts need to be noted:
1) The FDA commissioner overruled his advisory board in 1983 to allow Aspartame into our food supply.
2) There is NO nutritional value to Aspartame.
3) The symptoms of Attention Deficit Disorder ( ADD) are contained within the list of complaints symptoms presented to the FDA regarding Aspartame
4) The incidence/diagnosis of Obesity, malignant tumors, ADD, anxiety and other diagnosis have all increased in epidemic proportions since the 1983 introduction of Aspartame into the food supply.
5) Many of the original studies were manipulated and poorly
Note the summary below ( excerpt from www.wnho.net posted 3/12/2004): A few of the relevant findings summarized from various documents describing the FDA Task Force Report:
* "Excising masses (tumors) from live animals, in some cases without histologic examination of the masses, in others without reporting them to the FDA." (Schmidt 1976c, page 4 of US Senate 1976b) Searle's representatives, when caught and questioned about these actions, stated that "these masses were in the head and neck areas and prevented the animals from feeding." (Buzzard 1976a) "Failure to report to the FDA all internal tumors present in the experimental rats, e.g., polyps in the uterus, ovary neoplasms as well as other lesions." (Gross 1987a, page 8).
* "Instead of performing autopsies on rhesus monkeys that suffered seizures after being fed aspartame, the company had financed a new monkey seizure study with a different methodology that showed no problems." (Gordon 1987, page 496 of US Senate 1987)
* "Reporting animals as unavailable for necropsy when, in fact, records indicate that the animals were available but Searle choose not to purchase them." (Schmidt 1976c, page 5 of US Senate 1976b)